Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sachiko Furuichi"'
Autor:
Soko Kasai, Sharif Uddin Ahmed, Masato Okamoto, Akiko Sasai, Yoshihiro Uto, Tetsuya Oshikawa, Sachiko Furuichi, Tomoyuki Tano, Hitoshi Hori, Mitsunobu Sato, Hideko Nagasawa, Shin Kan
Publikováno v:
International Journal of Cancer. 116:571-578
We investigated in the current study the effect of TX-1877, a bifunctional hypoxic cell radiosensitizer, in augmenting anticancer host response. In the syngeneic squamous cell carcinoma-bearing mouse model, a single administration of TX-1877 signific
Autor:
Mitsunobu Sato, Go Ohe, Osamu Takeuchi, Sachiko Akashi, Kunisuke Himeno, Shizuo Akira, Masato Okamoto, Kensuke Miyake, Tetsuya Oshikawa, Shinya Ohkubo, Tomoyuki Tano, Sachiko Furuichi, Sharif Uddin Ahmed
Publikováno v:
Clinical and Vaccine Immunology. 11:483-495
A 55-kDa protein named AILb-A, isolated from the seed extract of Aeginetia indica L., a parasitic plant, induces a Th1-type T-cell response and elicits a marked antitumor effect in tumor-bearing mice. In the present study, we examined the role of Tol
Autor:
Hideo Yoshida, Sachiko Furuichi, Motoo Saito, Masato Okamoto, Sharif Uddin Ahmed, Yoshiki Ryoma, Tetsuya Oshikawa, Shuzo Matsubara, Hidetomo Nishikawa, Yoichiro Moriya, Mitsunobu Sato, Go Ohe
Publikováno v:
International Immunopharmacology. 3:643-655
We have previously isolated a lipoteichoic acid (LTA)-related molecule (OK-PSA) from OK-432, a streptococcal agent, by affinity chromatography on a CNBr-activated Sepharose 4B bound TS-2 monoclonal antibody (mAb) that neutralizes the interferon (IFN)
Publikováno v:
Japanese jornal of Head and Neck Cancer. 29:618-622
Autor:
Tomoyuki Tano, Hidetomo Nishikawa, Masato Okamoto, Yoichiro Moriya, Sachiko Furuichi, Motoo Saito, Tetsuya Oshikawa, Go Ohe, Mitsunobu Sato, Sharif Uddin Ahmed, Hideo Yoshida
Publikováno v:
Cancer Immunology, Immunotherapy. 50:408-416
We isolated the lipoteichoic-acid-related molecule (OK-PSA) from OK-432, a streptococcal preparation, by affinity chromatography on CNBr-activated Sepharose-4B-bound monoclonal antibody TS-2, which neutralizes the interferon (IFN)-gamma-inducing acti
Autor:
Masato Okamoto, Hidetomo Nishikawa, Sharif Uddin Ahmed, Tetsuya Oshikawa, Go Ohe, Sachiko Furuichi, Mitsunobu Sato, Hideo Yoshida, Tomoyuki Tano
Publikováno v:
Japanese jornal of Head and Neck Cancer. 27:651-657
Toll-like recetor (TLR) 4遺伝子発現と免疫療法剤 (OK-432およびその活性成分OK-PSA) の効果との関連につき検討した。OK-PSAの抗腫瘍免疫活性はTLR4の発現に依存して発揮される事が示された。OK-432
Autor:
Masato Okamoto, Kenji Hiura, Tetsuya Oshikawa, Kunihoro Terai, Yasuo Ohba, Keiji Moriyama, Mitsunobu Sato, Hideo Yoshida, Hidetomo Nishikawa, Sachiko Furuichi, Go Ohe
Publikováno v:
Cancer. 89:1966-1975
BACKGROUND. Osteoclastic bone resorption is an important step in bone invasion in several malignancies. Although interleukin (IL)-6 accelerates osteoclastic bone resorption, it remains unclear whether IL-6 may be involved in bone invasion of oral can
Autor:
Hidetomo Nishikawa, Hideo Yoshida, Go Ohe, Toru Sakai, Takashi Bando, Mitsunobu Sato, Shinya Ohkubo, Tetsuya Oshikawa, Masato Okamoto, Sachiko Furuichi, Kunisuke Himeno
Publikováno v:
Immunopharmacology. 49:377-389
We have isolated 55 kDa protein from the seed extract of Aeginetia indica L. (AIL), a parasitic plant, by an affinity chromatography on N-hydroxysuccinimide (NHS)-activated Sepharose High Performance column bound F3 monoclonal antibody which neutrali
Autor:
Go Ohe, Mitsunobu Sato, Tetsuya Oshikawa, Hideo Yoshida, Masato Okamoto, Hidetomo Nishikawa, Sachiko Furuichi
Publikováno v:
Anti-Cancer Drugs. 11:165-173
It has been suggested that certain antitumor agents stimulate antitumor immunity. In the present study, we examined whether cisplatin and 5-fluorouracil (5-FU) accelerate the antitumor host responses in head and neck cancer patients. Two groups of pa
Autor:
Ken Matsumoto, Sachiko Furuichi, Takashi Horie, Shu Hashimoto, Junji Yodoi, Yasuhiro Gon, Shuichiro Maruoka, Kiichi Hirota, Ikuko Takeshita
Publikováno v:
Biochemical and Biophysical Research Communications. 258:443-447
We examined the regulatory role of a reduction/oxidation (redox) control protein, thioredoxin (TRX), in tumor necrosis factor-alpha (TNF-alpha)-induced p38 MAP kinase activation and p38 MAP kinase-mediated cytokine expression utilizing TRX-transfecte